Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 220
Report Code : HC-1048
Cardiovascular Information System Market Overview: Cardiovascular system comprises the blood vessels and heart and It carries nutrients and oxygen to other parts of the body and removes carbon dioxide from them. Cardiovascular information system enlightened database system maintained by a cardiologist (specially trained medical professionals in heart-related treatments) used to manage the data of patient treatment programs, the enormous images files like 2D echo, ECG and MRI etc, treatment summaries and results created during the course of treatment and diagnosis. This CVIS is a special kind of Electronic health record used in cardiology to streamline patient care, improves employee work accuracy, better communications with referred doctors and image/ cardiology asset accessibility. Rising demand for information systems in healthcare services is expected to fuel the growth of cardiovascular information systems market. They are advantageous over traditional methods of data handling and validations and decreased the manual effort and improved the efficiency of the process. Along with this, the cardiovascular information system has a tremendous demand in healthcare settings due to the high patient pool and boosted the growth of the market. Further, increasing capital investment by healthcare sectors has created potential opportunities for robust growth of cardiovascular information systems market. Additionally, cardiovascular information system improves the patient care and helps in better management of cardiac disorders. Cardiovascular information system market is dominated by North America and Europe due to the high adoption rate among the end users and expected to remain dominant throughout the forecast period. Changing economic conditions and increasing awareness of population in the Asia Pacific region is expected to create a number of opportunities for cardiovascular information system service provides. Latin America and Rest of World Cardiovascular information systems market are expected to account a small share in the global market. Cardiovascular Information Systems market players include Siemens Healthcare, Elekta AB, GE Healthcare, AGFA Healthcare, Koninklijke Philips N.V., Fujifilm Medical Systems, Digisonics, Cerner Corporation, Merge Healthcare, Lumedx, McKesson Corporation, Philips Healthcare, McKesson Corporation. Cardiovascular Information System Market Segmentation: By Type CVIS C-PACS By Component Software Services Hardware By Deployment On-Premise Remote Cloud-Based Onsite By Application Catheterization Lab CVIS Solutions Echocardiography Lab CVIS Solutions Electrophysiology Lab CVIS Solutions Nuclear Cardiology CVIS Solutions Cardiothoracic Center CVIS Solutions ECG Studies/Holter monitoring CVIS Solutions Pacemaker/ICD Lab CVIS Solutions By End User Hospitals Diagnostic Laboratories Outpatient Centres Clinics By Region Europe North America APAC Latin America Rest of World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on global cardiovascular information system market By Type, By Component, By Deployment, By Application, By End User and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Cardiovascular system comprises the blood vessels and heart and It carries nutrients and oxygen to other parts of the body and removes carbon dioxide from them. Cardiovascular information system enlightened database system maintained by a cardiologist (specially trained medical professionals in heart-related treatments) used to manage the data of patient treatment programs, the enormous images files like 2D echo, ECG and MRI etc, treatment summaries and results created during the course of treatment and diagnosis. This CVIS is a special kind of Electronic health record used in cardiology to streamline patient care, improves employee work accuracy, better communications with referred doctors and image/ cardiology asset accessibility.
Rising demand for information systems in healthcare services is expected to fuel the growth of cardiovascular information systems market. They are advantageous over traditional methods of data handling and validations and decreased the manual effort and improved the efficiency of the process. Along with this, the cardiovascular information system has a tremendous demand in healthcare settings due to the high patient pool and boosted the growth of the market. Further, increasing capital investment by healthcare sectors has created potential opportunities for robust growth of cardiovascular information systems market. Additionally, cardiovascular information system improves the patient care and helps in better management of cardiac disorders.
Cardiovascular information system market is dominated by North America and Europe due to the high adoption rate among the end users and expected to remain dominant throughout the forecast period. Changing economic conditions and increasing awareness of population in the Asia Pacific region is expected to create a number of opportunities for cardiovascular information system service provides. Latin America and Rest of World Cardiovascular information systems market are expected to account a small share in the global market.
Cardiovascular Information Systems market players include Siemens Healthcare, Elekta AB, GE Healthcare, AGFA Healthcare, Koninklijke Philips N.V., Fujifilm Medical Systems, Digisonics, Cerner Corporation, Merge Healthcare, Lumedx, McKesson Corporation, Philips Healthcare, McKesson Corporation.
Cardiovascular Information System Market Segmentation:
By Type
By Component
By Deployment
By Application
By End User
By Region
Competitive Landscape:
FutureWise Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Cardiovascular Information System Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Cardiovascular Information System Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Cardiovascular Information System Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Cardiovascular Information System Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. CVIS 7.2. C-PACS 8. Cardiovascular Information System Market, By Component Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Software 8.2. Services 8.3. Hardware 9. Cardiovascular Information System Market, By Deployment Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. On-Premise 9.2. Remote 9.3. Cloud-Based 9.4. Onsite 10. Cardiovascular Information System Market, By Applications Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Catheterization Lab CVIS Solutions 10.2. Echocardiography Lab CVIS Solutions 10.3. Electrophysiology Lab CVIS Solutions 10.4. Nuclear Cardiology CVIS Solutions 10.5. Cardiothoracic Center CVIS Solutions 10.6. ECG Studies/Holter monitoring CVIS Solutions 10.7. Pacemaker/ICD Lab CVIS Solutions 11. Cardiovascular Information System Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Hospitals 11.2. Diagnostic Laboratories 11.3. Outpatient Centres 11.4. Clinics 12. North America Cardiovascular Information System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Cardiovascular Information System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Cardiovascular Information System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Cardiovascular Information System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Siemens Healthcare 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Elekta AB 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. GE Healthcare 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. AGFA Healthcare 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Koninklijke Philips N.V 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Fujifilm Medical Systems 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Cerner Corporation 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Merge Healthcare 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Lumedx 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10. McKesson Corporation 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11. Philips Healthcare 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12. McKesson Corporation 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Cardiovascular Information System Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Cardiovascular Information System Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Cardiovascular Information System Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Cardiovascular Information System Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. CVIS 7.2. C-PACS
8. Cardiovascular Information System Market, By Component Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Software 8.2. Services 8.3. Hardware
9. Cardiovascular Information System Market, By Deployment Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. On-Premise 9.2. Remote 9.3. Cloud-Based 9.4. Onsite
10. Cardiovascular Information System Market, By Applications Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Catheterization Lab CVIS Solutions 10.2. Echocardiography Lab CVIS Solutions 10.3. Electrophysiology Lab CVIS Solutions 10.4. Nuclear Cardiology CVIS Solutions 10.5. Cardiothoracic Center CVIS Solutions 10.6. ECG Studies/Holter monitoring CVIS Solutions 10.7. Pacemaker/ICD Lab CVIS Solutions
11. Cardiovascular Information System Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Hospitals 11.2. Diagnostic Laboratories 11.3. Outpatient Centres 11.4. Clinics
12. North America Cardiovascular Information System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Cardiovascular Information System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Cardiovascular Information System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific Cardiovascular Information System Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Siemens Healthcare 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Elekta AB 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. GE Healthcare 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. AGFA Healthcare 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Koninklijke Philips N.V 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Fujifilm Medical Systems 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Cerner Corporation 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Merge Healthcare 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Lumedx 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10. McKesson Corporation 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11. Philips Healthcare 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12. McKesson Corporation 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics